Alkem Laboratories Limited
ALKEM
Rank in Stocks
#2813
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Share Price
$55.19
Last synced: 2026-10-21
Market Cap
$6.60B
Change (1 day)
-0.06%
Change (1 year)
-12.43%
Country
IN
Trade Alkem Laboratories Limited (ALKEM)
Category
Healthcare
Revenue for Alkem Laboratories Limited (ALKEM)
Revenue in Jun 2026 TTM: $1.66B
According to Alkem Laboratories Limited latest financial reports the company's current revenue (TTM) is $1.66B. In 2024 the company made a revenue of $1.51B an increase over the revenue in the year 2023 that was $1.41B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Alkem Laboratories Limited from 2010 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $1.66B | 9.80% |
| 2025 | $1.52B | 0.58% |
| 2024 | $1.51B | 6.78% |
| 2023 | $1.41B | 0.75% |
| 2022 | $1.40B | 16.24% |
| 2021 | $1.21B | 10.84% |
| 2020 | $1.09B | 3.92% |
| 2019 | $1.05B | 7.90% |
| 2018 | $969.78M | 11.98% |
| 2017 | $866.05M | 17.92% |
| 2016 | $734.41M | 23.43% |
| 2015 | $595.01M | 15.94% |
| 2014 | $513.19M | 20.29% |
| 2013 | $426.63M | 10.75% |
| 2012 | $385.23M | 3.89% |
| 2011 | $370.79M | 23.92% |
| 2010 | $299.23M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 297.25% |
IN
|
